CELEMICS Trademark

Trademark Overview


On Tuesday, May 30, 2023, a trademark application was filed for CELEMICS with the United States Patent and Trademark Office. The USPTO has given the CELEMICS trademark a serial number of 98018569. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 24, 2024. This trademark is owned by CELEMICS, Inc.. The CELEMICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biotechnological preparations, namely, reagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purpose...

Research and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncology, cardiovascular disease neurology, immunology, and genomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in t...
celemics

General Information


Serial Number98018569
Word MarkCELEMICS
Filing DateTuesday, May 30, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements


Description of MarkThe mark consists of the word "CELEMICS" with a helix to the left of the word.
Goods and ServicesBiotechnological preparations, namely, reagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; chemical preparations for use in DNA analysis for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; in vitro diagnostic preparations for medical purposes; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncology, cardiovascular disease neurology, immunology, and genomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; chemical research; research for medical products, namely, medical research; scientific research in the nature of conducting clinical trials for others in the field of oncology, cardiovascular disease, neurology, immunology, and genomics; biotechnology research; biochemical research; providing information of scientific research.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELEMICS, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul, 08506
KR

Party NameCELEMICS, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul, 08506
KR

Trademark Events


Event DateEvent Description
Friday, June 2, 2023NEW APPLICATION ENTERED
Thursday, June 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 30, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 22, 2024ASSIGNED TO EXAMINER
Friday, March 1, 2024NON-FINAL ACTION WRITTEN
Friday, March 1, 2024NON-FINAL ACTION E-MAILED
Friday, March 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 12, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, June 12, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 12, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, June 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2024PUBLISHED FOR OPPOSITION
Monday, March 10, 2025TEAS STATEMENT OF USE RECEIVED